专业监测看板

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

药物 / 成分：iC9.GD2.CAR.IL-15 T Infusion

登记的停止原因（原文）：interim analysis

Does MI Have a Therapeutic Role in Arthroscopic Rotator Cuff Repair?

药物 / 成分：Motor Imagery、Physical Therapy

登记的停止原因（原文）：Due to the continuation of my PhD thesis process, patient admission will begin after the completion of my PhD graduation.

The CHALLENGER Registry

药物 / 成分：Numen SILK coil embolization system

登记的停止原因（原文）：FDA request pause in study and an IDE application to be submitted

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

药物 / 成分：BI 1831169、anti-PD-1 antibody

登记的停止原因（原文）：Sponsor decision - temporary enrolment hold as a precautionary measure following a safety event.

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

药物 / 成分：Bone Scan、Cabozantinib S-malate、Cisplatin、Computed Tomography

登记的停止原因（原文）：Other - Extend the observation period for current patients

Management of Acute Tinnitus With Migraine Medications

药物 / 成分：Nortriptyline、Topiramate、Paroxetine、Verapamil

登记的停止原因（原文）：Enrollment temporarily paused pending IRB continuing review; recruitment expected to resume.

A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men and Women

药物 / 成分：BI 3031185、Midazolam、Placebo

登记的停止原因（原文）：Sponsor decision - hold following the evaluation of a safety event. No current sites in the US.

Adaptation and Normalization of a Verbal Episodic Memory Test in French Sign Language

药物 / 成分：Questionnaire and Physical Exam、Questionnaire and Physical Exam

登记的停止原因（原文）：Inclusions suspended during the period between phase 1 (adaptation of the test in French sign Language) and phase 2 (inclusion for the standardization of the test).

Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitor

药物 / 成分：Upadacitinib <15 MG [Rinvoq]

登记的停止原因（原文）：Evolution of treatment sequencing for JAK inhibitors

Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors

药物 / 成分：Biospecimen Collection、Meditation Therapy、Meditation Therapy、Meditation Therapy

登记的停止原因（原文）：Accrual Goal Met

CandyCollect Strep Throat Testing

药物 / 成分：CandyCollect、Lollipop Swab

登记的停止原因（原文）：loss of funding

EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden

药物 / 成分：Liver-resection or ablation、2nd line chemotherapy

登记的停止原因（原文）：Not enough patients

Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

药物 / 成分：Sodium Thiosulfate

登记的停止原因（原文）：This study will be closing at CCHMC and may be transferred to a principal investigator at another insitutiton.

Personalized Treatment in Thyroid Disorders

药物 / 成分：Cervical Collar Therapy Indicator (COTI)

登记的停止原因（原文）：Funding issues

Incidence and Risk Factors for Persistent Post-sternotomy Pain After Cardiac Surgery in Local Chinese Population: a Prospective Cohort Study

登记的停止原因（原文）：No manpower and funding for the study.

Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

药物 / 成分：Neratinib、Divalproex Sodium

登记的停止原因（原文）：Pending amendment approval

CLEANer Aspiration for Pulmonary Embolism

药物 / 成分：Cleaner Pro Thrombectomy System

登记的停止原因（原文）：Enrollment in the study administratively paused pending modifications to the study device design

Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory

药物 / 成分：Decitabine、Pembrolizumab、Venetoclax

登记的停止原因（原文）：Accrual goal Met

8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia

药物 / 成分：8-Chloroadenosine、Venetoclax

登记的停止原因（原文）：Safety Issues, status is being updated per PI due to safety issues. Study is now Temporarily Closed to Accrual.

CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery to Improve Treatment of Melanoma Brain Metastases

药物 / 成分：Emavusertib、Pembrolizumab、Stereotactic Radiosurgery、Magnetic Resonance Imaging

登记的停止原因（原文）：transition to new institution